ArticleFrontiers in immunology2025
Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia.
Song Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.